1. Division of Hematology and Immunology, Medicine, Kanazawa Medical University, Ishikawa, Japan;
2. Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
3. Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
4. Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;
5. Chemotherapy and Oncology Center, Osaka University Hospital, Osaka, Japan;
6. Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan;
7. Department of Hematology, Takamatsu Red Cross Hospital, Japan;
8. Louis Pasteur Center for Medical Research, Kyoto, Japan;
9. Department of Emergency, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan;
10. Department of Hematology, JA Mie Kouseiren Matsusaka Central General Hospital, Matsusaka, Japan;
11. Department of Hematology, Itami City Hospital, Itami, Japan;
12. Osaka Rheumatology Clinic, Tokyo Medical University, Osaka, Japan;
13. Department of Respiratory Medicine, Yodogawa Christian Hospital, Osaka, Japan;
14. Department of Pathology, Kansai Rosai Hospital, Hyogo, Japan;
15. Department of Diagnostic Pathology, Cytology Osaka International Cancer Institute Hospital, Osaka, Japan;
16. Rheumatic Diseases Center, Hohnan Kakogawa Hospital, Kakogawa, Japan;
17. Hematology/Respiratory Medicine Kanazawa University Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa, Japan;
18. Department of Organic Fine Chemicals, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan